This article reports the results of the most recent in a series of EHSRE workshops designed to synthesize the current state of the field in Andrology and provide recommendations for future work (for details see Appendix). Its focus is on methods for detecting sperm DNA damage and potential application of new knowledge about sperm chromatin organization, vulnerability and repair to improve the diagnosis and treatment of clinical infertility associated with that damage. Equally important is the use and reliability of these tests to identify the extent to which environmental contaminants or pharmaceutical agents may contribute to the incidence of sperm DNA damage and male fertility problems. A working group (for workshop details, see Appendix) under the auspices of ESHRE met in May 2009 to assess the current knowledgebase and suggest future basic and clinical research directions. This document presents a synthesis of the working group's understanding of the recent literature and collective discussions on the current state of knowledge of sperm chromatin structure and function during fertilization. It highlights the biological, assay and clinical uncertainties that require further research and ends with a series of 5 key recommendations.
Background and rationale
Traditionally, the diagnosis of male infertility is based upon microscopic assessment and analysis of sperm concentration, motility and morphology as routine indicators of human semen quality. These indicators provide fundamental information about sperm production upon which clinicians base their initial diagnosis. As emphasized in previous ESHRE reports, it is imperative that semen analysis be performed to the highest standards. To this end ESHRE's special interest group in Andrology (SIGA) has been instrumental in providing formal training programmes and external quality control schemes. However, even with appropriate quality assurance, traditional semen parameters provide a limited degree of prognostic and diagnostic information and their predictive power is highest primarily at the lower ranges of the spectrum (Lefièvre et al., 2007; Lewis, 2007) . Sperm production is only part of the story. Sperm chromatin and DNA integrity is essential to ensure that the fertilizing sperm can support normal embryonic development of the zygote. To better inform treatment pathways and, more importantly, to ensure a generation of healthy children from assisted reproductive technologies (ART), we urgently require tests of sperm function, including the normalcy of sperm DNA, that provide high quality and robust diagnostic and prognostic information.
Improved tools for the diagnosis of male infertility clearly benefit the clinician's ability to treat an infertile couple seeking help. In addition, these tools are important in a broader social context. Infertility is no longer solely a personal problem; it has become a public health issue. In developed countries such as the European Union, birth rates have been declining at an unprecedented rate over the past half century. The extent to which birth rates may be impacted by contemporary life style factors, or by exposures to environmental contaminants or pharmaceuticals remains to be determined, but is of growing concern. Environmental epidemiology studies, which measure differences in health outcomes between groups of individuals exposed to environmental contaminants and unexposed controls, are beginning to address this question. Valid indicators of sperm quality and fertility are essential for these epidemiology studies to achieve their objectives. Equally important is the potential demographic and economic impact of the increased use of ART to treat subfertility. Depending on the country, up to 3.9% of EU births are currently from ART (Nyboe Andersen et al., 2009) . Therefore, the use of ART may result in significant demographic and economic impacts. Part of the latest population policy strategy takes this into consideration (European Parliament, 2008; Ziebe and Devroey, 2008) .
Significant progress has been made towards the development of reliable tests for sperm chromatin integrity and DNA damage. A landmark paper by Evenson et al. (1980) suggested that assessment of DNA integrity in sperm may be a useful and potentially independent marker of fertility for both animals and men. Clinical data followed, demonstrating higher levels of chromatin damage in men with severe semen defects (Sun et al., 1997) and the potential negative impact of high levels of sperm DNA damage on both natural (Evenson et al., 1999; Spanò et al., 2000) and ART conception (Larson et al., 2000) . Subsequently, the assessment of DNA damage in the male germ line and the study of its consequences have received considerable attention. However, key questions, particularly regarding clinical significance, remain to be answered (Collins et al., 2008) .
In animals, where DNA damage can be experimentally induced in the paternal germ line by, for example, chemotherapeutic agents, clear and strong associations have been shown between damage to the paternal genome and embryo development including effects on the new born and subsequent generations (Auroux et al., 1990; Hales et al., 1992; Fernandez-Gonzalez et al., 2008; Delbès et al., 2009 ). These experiments are not feasible in humans, but provide clear warnings of the potential impact of for example cancer treatments in men for the next and subsequent generations. With long-term follow-up on children born as a result of ART still in its infancy, it is essential that we are able to appreciate and translate findings from animals to humans to understand the clinical implications of using spermatozoa with highly damaged DNA in ART. Progress in this area will be dependent on fundamental improvements in our understanding of the causes and consequences of DNA damage in the male germ line and the development of robust diagnostic tests that can be incorporated into the clinical assessment of male infertility patients.
Biological uncertainties: the mysteries unfolding
The nature of the germ cell and sperm chromatin
In developing better methods for assessing clinical sperm samples for use in ART or as indicators in environmental epidemiology studies, a series of assays have been designed that evaluate the integrity of sperm DNA. These include, but are not limited to, the TUNEL assay, the sperm chromatin structure assay (SCSA), the Comet Assay and the Sperm Chromatin Dispersion Assay (for details, see section: How do we assess sperm DNA damage?) These assays are already in clinical use in some infertility centres for two primary reasons. The first is to attempt to predict future ART outcome or explain previous failure. The second is to be able to detect sperm with DNA that is sufficiently damaged as to result in transmission of genetic defects to the embryo and subsequent offspring. To optimize ART, especially ICSI, clinicians would like to be able to choose sperm with intact DNA. As conducted at present, these DNA integrity assays provide an assessment of the distribution of cells in a given ejaculate. However, these assays also destroy the cells and so cannot be used to identify or select an individual intact sperm for use in ICSI. Moreover, for most of these assays, we do not have a good understanding of what kinds of lesions they are measuring. Before they become routine clinical assays, we need to comprehend what these assays are telling us about the integrity of the male genome. This will come from a thorough knowledge of the sperm chromatin structure and how it is packaged.
Most DNA in mature human sperm is bound to protamines, as somatic histones are replaced during spermiogenesis. However, biochemical analyses of human sperm proteins indicate retention of some histones resulting in a nuclear protein composition that is about 90% protamine and 10% histone. We have a fairly clear understanding of how the protamines package human sperm DNA. The protamine-bound DNA is coiled into tightly compacted toroids that contain about 50 kb of DNA (Conwell et al., 2003; Hud et al., 1993) , although the histone-bound DNA is believed to be organized into nucleosomal chromatin (Pittoggi et al., 1999; Zalenskaya et al., 2000; Wykes and Krawetz, 2003; van der Heijden et al., 2006; . Sperm DNA is so well protected that, unlike somatic cell chromatin, it is resistant to nucleases (Sotolongo et al., 2003) and sonication (Tateno et al., 2000) . The precise packaging of the histone portion of sperm chromatin is not well understood. We are only now beginning to appreciate how this histone bound DNA is distributed throughout the chromatin, but we still do not know the size of the histone bound DNA segments. Recent evidence suggests that histone bound DNA in sperm cells is associated with gene families that are important for cell differentiation and early embryo patterning .
How are the current assays expected to interact with sperm DNA that is associated with protamine versus histone fractions? Reagents used in the TUNEL assay, for example, would not be expected to be able to access the DNA packaged and stabilized by protamines into toroids. This is because it uses the action of the enzyme terminal deoxynucleotidyl transferase (TdT) and if protamine bound chromatin is resistant to nucleases, it would be expected to be resistant to other enzymes as well. However, improperly stabilized protamine and histone bound DNA would be expected to be accessible to most of the assays currently in use for sperm DNA assessment. TdT can access DNA breaks in nucleosomal DNA, so the TUNEL assay would be expected to reveal this type of chromatin structure. The SCSA partially denatures sperm with acid which would preferentially extract histones rather than protamines (Ballachey et al., 1987; Larson-Cook et al., 2003) . Therefore, the SCSA would also be expected to identify single stranded DNA in histone bound sperm chromatin. However, SCSA would also measure single-stranded DNA in the protamine bound DNA if the stabilization of the protamine-DNA complex have been compromised (Dias et al., 2006) Finally, most protocols for the comet assay involve high salt extraction in the presence of a reducing reagent which removes both protamines and histones (Tomsu et al., 2002; McVicar et al., 2004) . The Comet assay therefore probably detects chromatin breaks in both types of chromatin with equal efficiency. A more detailed discussion of these points can be found elsewhere (Shaman and Ward, 2006) . The questions that we need to address include (i) how can we specifically assess the DNA damage in histone bound versus protamine bound DNA in sperm chromatin (ii) how meaningful is this distinction for clinical prognosis and (iii) how can we assess the damage to the whole genome as opposed to specific fractions?
Related to these questions is our limited understanding of how the sperm chromatin is formed during spermiogenesis. We know that protamines largely replace the histones during sperm nuclear condensation and that during this process the sperm DNA is unwound by topoisomerases and other proteins through the normal and necessary induction of strand breaks (Boissonneault, 2002; Kwan et al., 2003) . It is clear that when this packaging is not complete, DNA single and double strand breaks appear in the fully mature sperm (Marcon and Boissonneault, 2004) . Furthermore, the protamine deposition can also be incomplete, resulting in ratios of histone to protamine and of protamines 1 to protamines 2 that differ from normal. Both types of defects in spermiogenesis are associated with subfertility or infertility (Aoki et al., 2006a, b; Oliva, 2006 ). Yet, we do not know how topoisomerase cleaves sperm DNA during spermiogenesis or how the protamines interact to form sperm chromatin toroids.
These are just some examples of the uncertainties that cloud our understanding of how abnormalities in sperm chromatin structure may be used to guide clinical decisions. A host of additional aspects of sperm DNA packaging are also emerging as potential indicators of prognosis, including chromosome position within the sperm nucleus (Zalenskaya and Zalensky, 2004) , the presence of mature mRNAs (Ostermeier et al., 2002 (Ostermeier et al., , 2004 and newly described pi and microRNAs in sperm chromatin (Li et al., 2001; Martins and Krawetz, 2005; Carrell, 2008) . Currently, we know a lot about how sperm chromatin packaging differs from somatic cell packaging, but we do not understand the specifics of how that packaging occurs.
This will be important for a real understanding of what current sperm DNA assays are measuring.
Changes in sperm chromatin during sperm transport from the testis to the oocyte: the role of zinc Zinc is incorporated into the sperm nucleus during spermiogenesis. The chromatin contains around 8 mmol Zn 2þ /kg which equates to one zinc ion for every 10 base pairs of the DNA, equalling one turn of the DNA-protamine helix . However, the role of zinc in sperm chromatin structure and function is only partly understood. The chromatin of more than 90% of human spermatozoa can be experimentally decondensed in vitro by exposure of freshly ejaculated sperm to the anionic detergent SDS together with the divalent cation chelating EDTA (Björndahl and Kvist et al., 1988) . This observation suggests a potential rapid mechanism for decondensation of the sperm chromatin that relies on Zn 2þ depletion and interruption of macromolecules. Thus, at ejaculation, human sperm exhibit zinc-dependent chromatin stability. However, upon in vitro culture, human sperm become more resistant to decondensation and subsequently require disulfide bond reduction to enable unpackaging of the chromatin. This change is enhanced when zinc is withdrawn from sperm in vitro, and can, to a large extent, be counteracted by storing sperm in a buffer containing Zn 2þ . Although the role of zinc-to bind thiols-is simple, the consequences of this organization are complex based upon the following observations. (i) Zinc primarily contributes to rapidly reversible chromatin stability. (ii) If zinc is lost, it will not contribute to a sufficient stabilization of the chromatin, leaving the DNA more accessible and therefore more vulnerable to factors that might degrade it (endogenous enzymes or exogenous chemicals). (iii) Extraction of zinc can elicit chromatin decondensation if repulsion of macromolecules (DNA-protein filaments) is induced simultaneously, e.g. by phosphorylation or in experimental studies by the action of detergents like SDS (Kvist et al., 1987) . (iv) If macromolecules are not repelling the chromatin threads, the lack of zinc can allow the formation of disulphide bridges (S -S dependent chromatin stability).
What happens to the sperm chromatin during ejaculation, liquefaction and after liquefaction during further processing for ART? The zinc content of the sperm head and the type of chromatin stability are influenced by the composition of the surrounding 'seminal fluid' which comprises a mixture of various secretions that vary during ejaculation, liquefaction and after ejaculation. Normally spermatozoa are expelled in the first ejaculatory expulsions suspended in the zinc-rich prostatic fluid and the zinc-chelating seminal vesicular fluid is expulsed in later fractions. Upon mixture during and after liquefaction, spermatozoa are thus exposed to a series of differing environments that can have a marked influence on chromatin stability (Bjö rndahl and Kvist, 2003) . Of clinical importance is that in some men the emptying of prostatic fluid is delayed and sperm are expelled in primarily zinc-chelating vesicular fluid, leading to extraction of zinc from the sperm chromatin (Bjö rndahl et al., 1991) . Several animal studies have reported that experimentally induced zinc deficiency affects sperm chromatin structure (Evenson et al., 1980) . However, studies in humans are sparse and the biological effects of a zinc depleted diet are yet to be fully explored.
Mechanisms of DNA damage in male germ cells and spermatozoa
One of the potential mechanisms often cited as a cause of DNA damage in the male germ line is abortive apoptosis. The general idea behind this assertion is that as male germ cells metamorphose into highly differentiated spermatozoa, they progressively loose their capacity to undergo programmed cell death in the form of apoptosis. Since these cells are transcriptionally and translationally silent, it could not be otherwise. Thus, instead of engaging in a complete apoptotic response leading to cell death, differentiating haploid germ cells are thought to undergo a restricted form of this process leading to DNA fragmentation in the nucleus whereas retaining the capacity to differentiate into mature functional spermatozoa that may still be capable of fertilization (Sakkas et al., 2004) . Clearly, haploid germ cells are capable of activating a process that resembles apoptosis in some respects because both caspase activation and phosphatidylserine exteriorization have been observed in human spermatozoa (Weng et al., 2002) . It is possible that by expressing apoptotic markers on their surface, senescent spermatozoa ensure that their ultimate phagocytosis in the female tract will be silent and not associated with a full-blown inflammatory response (Kurosaka et al., 2003) .
This default senescence pathway may resemble the intrinsic apoptotic cascade in many respects but in one important detail, it is very different. In an archetypal somatic cell, stimulation of the intrinsic apoptotic pathway leads to the sudden appearance of endonucleases that are either released from the mitochondria (such as endonuclease G) or activated in the cytosol (caspase-activated deoxyribonuclease) and then they move into the nucleus to cleave the intra-nucleosomal DNA. However, in spermatozoa the physical separation of the mitochondria and cytoplasmic space from the sperm nucleus means that such mechanisms cannot be operative. As a result, the claim that 'apoptosis' is a significant cause of DNA damage in human spermatozoa might not be true for cells entering this process as mature gametes. However, sperm mitochondria represent a major source of reactive oxygen species (ROS) in these cells (Koppers et al., 2008) , that can become activated during the intrinsic apoptotic pathway. The levels of DNA damage recorded in both unselected donors and patients attending an assisted conception clinic were highly correlated with the appearance of a marker for oxidative DNA damage, 8-hydroxy, 2 0 -deoxyguanosine (8OHdG; De Iuliis et al., 2009). Although these data could be interpreted in several different ways, one plausible explanation is that some DNA damage in the male germ line is the result of a programmed senescence pathway, characterized by the activation of mitochondrial ROS formation, oxidative DNA base damage and unresolved DNA strand breakage ).
If this is the case, then a key question is not what induces spermatozoa to undergo this restricted form of apoptosis-because this is their default condition. The real question is what prevents these cells from entering this pathway. The answer to this lies in defining pro-survival factors that will prevent spermatozoa from initiating apoptosis. There are undoubtedly many potential pro-survival factors for spermatozoa in the male and female reproductive tracts; their ultimate characterization is likely to help in the development of in vitro culture media that will preserve the functionality and genetic integrity of gametes used for assisted conception.
The nature of the DNA damage exhibited by human spermatozoa
In the literature, most authors simply talk of generic DNA damage without reference to any particular form of molecular lesion. The ability of the TUNEL and Comet assays to detect DNA damage in the male germ line clearly means that both single and double strand DNA breaks are prominent features of these cells (Irvine et al., 2000; Van Kooij et al., 2004 , Enciso et al., 2009 ). In addition, damaged sperm chromatin is known to contain base adducts. The major DNA adducts found in human sperm DNA are 8OHdG and two ethenonucleosides (1,N6-ethenoadenosine and 1,N6-ethenoguanosine). Although the former is a direct consequence of oxidative attacks on sperm DNA, the latter probably arise from exposure to 4-hydroxy-2-nonenal, a major product of lipid peroxidation (Badouard et al., 2008) . These findings, taken in conjunction with data revealing a high correlation between DNA damage and 8OHdG expression suggest that the former is commonly the product of oxidative stress originating as a consequence of the apoptotic mechanism described above, infiltrating leukocytes, redox-cycling xenobiotics or failed antioxidant defence systems. An interesting example of the latter, albeit in animals, is the powerful antioxidant protective environment in the epididymis which when disrupted, for example by deletion of glutathione peroxidase 5, can lead to abnormal levels of DNA compaction accompanied by increased miscarriage rates (Chabory et al., 2009) .
Another type of damage that has recently come to light is DNA cross-linking. In the tightly compacted chromatin that characterizes the mature sperm nucleus, opportunities for DNA -DNA or DNA -protein cross-linking are significantly greater than in the dispersed interphase nuclei of somatic cells. This susceptibility to crosslinking phenomena has been recognized for many years (Qiu et al., 1995) . Recently, in an analysis of the impact of estrogens on sperm chromatin structure, catechol estrogens were shown to form dimers that then covalently cross-linked the DNA so that it became completely resistant to the decondensation protocols employed in a Comet assay including treatment with reducing agents, detergents and broad spectrum proteases (Bennetts et al., 2008) . This susceptibility of sperm chromatin to cross-linking was subsequently confirmed using epigallocatechin gallate, the major antioxidant present in green tea (Bennetts et al., 2008) . Importantly, severely cross-linked chromatin is commonly encountered in populations of defective human spermatozoa (Windt et al., 1994) although the molecular basis of such superstabilization is still unknown. Finally two of the assays most commonly used to detect DNA damage in human spermatozoa assess the stability of sperm chromatin under severely acid (SCSA assay) or alkaline (alkaline Comet assay) assay conditions. The full nature of how these pH-exposures affect the sperm chromatin is not known with certainty at the present time.
Sperm epigenetics
One area of rapidly advancing interest is sperm epigenetics and the role that epigenetic marks in sperm chromatin may play in regulating development of the embryo (Biermann and Steger, 2007; Carrell, 2008) . Epigenetics refers to methods other than DNA coding changes (polymorphisms, mutations, deletions, etc.) that can alter or regulate the expression of genes (Nanassy and Carrell, 2008;  Sperm DNA: questions and answers Trasler, 2009 ). Presently, it appears that the major epigenetic regulators in sperm are DNA methylation, retention of pi and micro RNA's and binding of large portions of the genome with protamines, and post-translational modification mainly N-tail chemical modifications to retained histones of the sperm genome (Emery and Carrell, 2006) . It is increasingly clear that sperm epigenetics play a role in the function of the paternal DNA following fertilization and is therefore potentially an integral component of the possible effects of DNA damage on sperm function .
During late spermiogenesis, 85 -95% of histones are replaced in human sperm through a multi-step process (Oliva, 2006) . First, the histones undergo hyperacetylation then are replaced by testes-specific variants of the histones, followed by their replacement with transition proteins. The transition proteins are then rapidly replaced by two small, basic molecules termed protamine 1 and 2 (P1, P2). P1 and P2 are normally expressed in a 1:1 ratio in human sperm, and result in a much tighter packaging of the sperm DNA, resulting in a compaction of the nucleus and cessation of gene expression . Altered expression of protamines is associated with diminished sperm quality and reduced embryogenesis quality in couples undergoing IVF/ICSI (Aoki et al., 2006a, b; Oliva, 2006) .
The retained histones may present another possible source of epigenetic regulation of the sperm genome. Prior studies evaluating specific regions of the genome have indicated that histone retention may not be random (Gardiner-Garden et al., 1998 , Li et al., 2008 . Recent studies have further evaluated the potential role of the retained histones on a genome-wide basis and shown that retained histones are not randomly distributed throughout the genome. Rather they are preferentially retained in the promoter regions of genes required during embryogenesis, micro RNAs and imprinted genes . Each of these classes of genes is of interest from a developmental perspective, portending a possible role in early embryogenesis. To address this, the distribution of modified variants of the histones throughout the sperm genome has been analysed. It was found that H3K4Me2 and H3K4me3, which are gene 'activating' marks, were preferentially retained in developmental genes, some of which were also bivalently marked with H3K27me3, a 'silencing' mark. This bivalent marking is similar to the bivalent 'poising' of similar genes in embryonic stem cells . Further analysis of the genome-wide methylation of sperm DNA demonstrated that the regions of DNA bound to activating histone modifications were generally demethylated, a further activation signal. These novel findings are striking because they indicate that sperm genes may be packaged and epigenetically modified in a manner that is necessary for poising of the genes for early embryonic expression.
The potential implications of epigenetic gene poising in sperm are numerous, including the possible effects of aberrant spermiogenesis on epigenetic marking. Presently, the data indicate that oligozoospermic males have an increased incidence of abnormal methylation of CpGs in imprinted genes (Marques et al., 2004 (Marques et al., , 2008 Filipponi and Feil, 2009) . Recent data have shown that altered methylation is found in some, but not all, of imprinted genes in the sperm of men with abnormal protamine replacement (Hammoud et al., in press) . The potential link between general sperm DNA damage and epigenetic alterations is not yet understood, but may be very important. Such a link may help to explain the relationship between DNA damage and normal embryonic development.
Human studies of ambient chemical exposures and sperm DNA damage
Toxicology studies expose test species to toxicants of concern and determine associated health outcomes. The toxicology literature indicates that certain environmental contaminants can, at least at experimental doses, induce sperm DNA fragmentation (Evenson and Wixon, 2005) and/or induce oxidative stress in the testes (Aitken and Roman, 2007) . Although at least 70 000 chemicals are used in commerce, and at least 200 exogenous chemicals can be measured in most people at any given time, very few chemicals have been evaluated specifically for their sperm DNA damaging potential. Reproductive and multigenerational test protocols specified by federal and international agencies do not include a specific test for sperm chromatin integrity. Nevertheless, numerous epidemiologic and occupational studies have shown that exposure to at least five types of environmental chemicals, known to be ubiquitous in today's modern environment, can be associated with sperm oxidative stress or sperm DNA damage. It is important to note that epidemiology studies demonstrate associations between exposures and outcomes but do not provide definitive information about cause.
Pesticides
By their nature, pesticides and/or their metabolites are biologically active and ubiquitous in the environment due to wide scale commercial and private use. The impact of pesticides on sperm DNA damage has been evaluated in at least seven studies in the last 15 years, with four reporting positive associations (Perry, 2008) . Fenvalerate exposure was associated with higher % comet tail DNA and olive tail moment (Bian et al., 2004) and organophosphate exposure detected as urinary metabolites in sprayers was significantly associated with DNA fragmentation index measured using SCSA (Sanchez-Pena et al., 2004) . In the only environmental (versus occupational) exposure studies to date evaluating pesticides and DNA damage, higher levels of urinary chlorpyrifos, carbaryl and pyrethroid metabolites were associated with a higher percentage of comet tail DNA using the neutral comet assay (Meeker et al., 2004 (Meeker et al., , 2008 .
Phthalates
Phthalate esters are used in food packaging, personal care products and plastics. Therefore, environmental exposures are hard to avoid in today's world. In a sample of 379 men from subfertile couples attending an infertility clinic, urinary levels of two specific phthalate metabolites monoethyl phthalate and mono-(2-ethylhexyl) phthalate were associated with an increased percentage of comet tail DNA using the neutral comet assay (Hauser et al., 2007) . The levels of urinary phthalates among this sample were similar to levels found in the US general population.
Polychlorinated biphenyls
Polychlorinated biphenyls (PCBs), a class of persistent organic pollutants resulting from industrial production of transformers and electrical capacitors, are highly persistent and have known endocrine disrupting properties. Although the use of PCBs was banned in the mid-1970s, environmental residues accumulate in fats and human exposure continues, largely by consumption of contaminated fish and other food. The impacts of PCBs on sperm DNA integrity using the SCSA have been recently demonstrated in epidemiologic studies of European and Inuit populations Long et al., 2007) and in Swedish fishermen .
Metals
Metals are common in industrial processing and are distributed widely in air, water and soil. Two epidemiologic studies have suggested that non-essential metals can cause sperm DNA damage. Oxidative DNA damage in sperm measured using 8OHdG was correlated with cadmium in seminal plasma in 56 non-smoking study participants in China (Xu et al., 2003) . Increased DNA fragmentation in sperm measured using SCSA was correlated with blood lead levels in 80 battery plant workers in Taiwan (Hsu et al., 2009 ).
Air pollution
High levels of air pollution resulting from coal combustion was associated with increased sperm DNA fragmentation measured using SCSA in a longitudinal study of 36 men from the Czech Republic (Rubes et al., 2005) . The components of the air pollution were not identified but blood metals were not elevated in this group and subsequent studies implicated reactive intermediates of carcinogenic polyaromatic hydrocarbons present in the particulate fraction of the air pollution (Rubes et al., 2007) .
Although studies of each of these contaminants are limited, the accumulated epidemiologic evidence to date suggests exposures in our everyday environment can adversely affect the genetic integrity of the spermatozoon. However, the array of findings raises a number of questions about the underlying mechanisms through which environmental agents affect sperm production, structure and integrity. The future of this work relies largely on the field's ability to standardize methods of exposure and outcomes and its ability to work across clinical, epidemiologic and basic science disciplines to ask the right questions.
Among the environmental exposure studies to date, methods vary widely with respect to how exposures are defined and how sperm DNA damage is measured. Sound replication of research findings will require both valid and reliable exposure assessment measures, including evidence that the contaminant actually reaches the testis or comes into contact with sperm and validated methods for determining sperm DNA damage. In this regard, methods for detecting sperm DNA adducts that can be attributed to sources would be particularly informative. Epidemiologists are relying on clinical and basic scientists to establish the validity and precision of sperm DNA damage assays and to clarify what is actually being measured (for example, stability versus chromatin integrity). Once an assay makes its way into the reproductive biology literature, environmental epidemiologists may be quick to adopt its use as a meaningful outcome for reproductive health studies. Similarly, epidemiologic studies are designed to test exposure and outcome associations; however, there is reliance on basic science and toxicologic studies for insight into biologically plausible mechanisms that drive exposure-response relationships. In a reciprocal manner, basic scientists look to the epidemiologic data to determine whether associations they see in the lab are observed among humans in the general population or in clinical settings. Epidemiological studies seek to establish associations in large, unbiased and statistically meaningful samples of people. Together, well designed epidemiology and toxicology studies can inform clinicians about risks to sperm integrity posed by environmental contaminants and help them to advise their patients about avoiding such exposures.
Sperm DNA repair in oocytes, epigenetics and the potential consequences of faulty repair
Between the moment the spermatozoon fuses with the secondary oocyte and the first cleavage division (a period of 16 -20 h in the mouse and 18-27 h in humans), the highly condensed sperm nucleus unfolds, exchanging protamines for maternal histones and assumes the interphase chromatin configuration in the male pronucleus that is necessary for the semiconservative DNA replication in preparation for the first mitotic division of embryonic development. The period of pronuclear formation in the zygote is unique in a number of features.
Sperm derived nucleosomal chromatin contributes to paternal zygotic chromatin. Using a heterologous ICSI system with human sperm and mouse oocytes, paternal nucleosomes marked by the replication dependent histone isoforms H3.1/3.2 were present in the G1 stage male pronuclei (Van Der Heijden et al., 2008) . Additionally, examination of human multi-pronuclear zygotes showed these replication variants in paternal chromatin prior to DNA replication. This suggests that the epigenetic program originating from the paternal chromatin has the potential to be transmitted into further embryonic development (see section: Sperm epigenetics).
At least in the mouse, many post-translational histone modifications are asymmetrically present between the male and female pronucleus. Particularly in early G1 phase there are clear differences among histone N tail Lysine methylations (Van Der Heijden et al., 2005) . Although not as extensively researched, the same pattern is visible in humans (Van Der Heijden et al., 2009 ). This phenomenon is known as epigenetic asymmetry and demonstrates the very different nature of chromatin between the sexes, as a consequence of gamete specialization, although this does not necessarily hold at the level of each gene.
Double strand DNA breaks that are induced during the nucleosome to protamine exchange in elongating spermatids may lead to residual breaks in functioning spermatozoa, although this remains to be determined. Also, and especially in the epididymis, DNA damage could originate from external factors, notably ROS. In the mouse, it has been observed that repair of DNA breaks induced by irradiation is incomplete at the first cleavage division, as the level of chromosome aberrations could be influenced by repair inhibitors at the zygote stage (Matsuda et al., 1989) . Hence, integrity of the paternal genome also depends on the capacity of the oocyte to recognize DNA damage and repair it.
DNA repair before zygotic S-phase
Humans exhibit a relatively high load of reciprocal translocations (Bonduelle et al., 2002) , which are mainly of paternal origin. Because a DNA double strand break is a prerequisite for a reciprocal translocation to arise, one deduces that these must be repaired during the zygotic cell cycle. The decondensation of paternal chromatin after gamete fusion is followed by a phase of recondensation, which in the mouse can be monitored by detection of Histone3 Serine10ph (H3S10ph). In the recondensation stage, 1 h after sperm fusion, Sperm DNA: questions and answers double strand breaks can be visualized by chromatin domains positive for phosphorylation of Serine 139 of H2AX (called gamma H2AX). Spontaneously, gammaH2AX foci are visible at this stage in low numbers and only in the paternal chromatin. However, using one genetic source of sperm and four maternal oocyte genotypes, the frequency of DNA single strand breaks was strongly dependent on the maternal genotype. Mice with either the BALB/c hypomorphic DNA.PKcs allele or the very low activity scid DNA.PKcs allele, had the highest averages of around three breaks per male complement, which was about three times the frequency found in B6/CBA hybrid oocytes . The kinase DNA.PKcs is the key enzyme of the Non-Homologous End Joining (NHEJ) double strand DNA repair pathway. Subsequently, sperm were irradiated with a standard dose of 3 Gy a dose that damages sperm DNA. Sperm DNA damage translated into additional gamma H2AX foci that in number were highly correlated with the frequencies reported above, and so reflect DNA.PKcs activity. This experiment demonstrated that in the absence of normal DNA.PKcs alleles in oocytes, the capacity to repair DNA double strand breaks, either from a damaged sperm or from a post fusion paternal chromatin remodelling mechanical defect, is affected .
Findings in mice have been partly confirmed in human-mouse heterologous ICSI experiments. When sperm samples from oligo-astheno-teratozoospermic men were compared with normozoospermic donors, the fraction of nuclei without damage was lower (Derijck et al., 2007) . Again, these findings relate to a fraction of breaks showing slower repair that can be both of prefertilization origin or produced post-fertilization by an interaction between the male chromatin and the female chromatin remodelling environment on the road to pronucleus formation. The observation that motile ejaculated sperm with normal morphology can generate abnormal gam-maH2AX signalling patterns up to complete fragmentation supports the contention made earlier that sperm with normal appearance may nevertheless carry DNA damage.
Cytogenetic analysis of the male and female chromosome complements at the first cell cycle has been used to demonstrate the mutagenic effect of sperm irradiation. Abnormalities in first metaphase spreads revealed primarily chromosome type aberrations (inversions, translocations, fragments, etc.) . These abnormalities result when the DNA repair takes place before S-phase such that the rearranged chromosomes and chromosomal fragments are faithfully copied. In such studies scid oocytes (NHEJ defect oocytes) exhibited about twice the number of chromosome abnormalities than controls , again implying that DNA double strand break repair is executed before S-phase.
DNA repair in the zygotic S-phase
During S-phase, when the replication fork encounters a single strand break, or more likely a base modification that requires excision repair, a double strand break is created in the replication fork. These sites can also be visualized by gammaH2AX as well as by a number of repair proteins among which is RAD51, a key player of the homologous recombination repair (HRR) pathway. A possible consequence of a stalled replication fork is a non-homologous chromatid exchange (a quadriradial) that at zygotic mitosis segregates into a normal chromosome complement and a reciprocal translocation. RAD51 has been visualized in the pronuclei from the beginning of the S-phase until chromosome contraction at mitotic metaphase .
In mice with zygotes derived from genetically handicapped oocytes, especially in the HRR pathway (by the RAD54, RAD54B knock-out mutations) but also in the NHEJ pathway, the zygotes were extremely sensitive to the mutagen 4NQO (4-Nitroquinoline 1-oxide, a UV mimic agent). Low doses of 4NQO resulted in chromatid exchanges especially in the male pronucleus whereas higher doses caused a blockage at the pronucleus stage. These and other experiments using irradiation of zygotes before entering the S-phase showed that for all genotypes but especially for HRR mutants, the male pronuclei contain higher amount of RAD51 foci than female ones. This would indicate that the combination of damaged sperm and oocytes with suboptimal DNA repair (a possible scenario for suboptimal oocytes after ovulation induction) favours reciprocal translocation induction in the paternal chromosome complement.
Summarising, it is clear that we are only just obtaining an insight into the complexities of the DNA repair mechanisms in the early zygote. The data overwhelmingly suggest that an extra repair effort from the oocyte is required for damaged male chromatin. In compromised oocytes this may not be available.
Assay uncertainties: refinements on-going
How do we assess sperm DNA damage?
The methods discussed here are adaptations of techniques originally developed and validated for investigation of DNA in somatic cells. A crucial question is whether these adaptations are sufficient to enable reagents to get access to the compacted sperm DNA without inducing damage? Furthermore, it is essential that a method aimed at revealing sperm DNA disorders can compensate for the varying changes in the sperm chromatin structure occurring in vitro after ejaculation (Kvist et al., 1988) .
The methods designed to detect sperm DNA disorders primarily include (i) Specific detection of free DNA ends ('nicks') by enzymatic incorporation of marked nucleotides (TUNEL). (ii) Detection of DNA fragments by gel embedded single-cell electrophoresis after extended lysis of all nuclear proteins binding DNA (Comet) under neutral (detects double strand) and alkaline (double strand and single strand breaks) conditions. (iii) Detection of green fluorescence as a measure of intact double stranded DNA [Acridine Orange (AO) tests] combined with the detection of red fluorescence as a measure of acid induced denaturation which occurs preferentially at sites of pre existing DNA strand breaks.
An important issue with all these methods is whether the treatments used to prepare the sperm may themselves induce DNA damage. For example, in the comet assay it is typically necessary to include thiols, which are strongly reducing, to elute protamines attaching to and hindering fragmented DNA from migrating as a comet. Does this protamine S-S reduction induce DNA damage, possibly secondary to release of physical constraints on the DNA?
With respect to the AO test using flow cytometry, the red emitted fluorescence may not be limited to pre-existing DNA damage. The assay uses acid treatment to denature damaged DNA which then reacts with AO and fluoresces red. It is possible that sperm with inherently lower structural stability may be more accessible to the acid and more prone to acid induced DNA denaturation, even in the absence of pre-existing strand breakage. An example is that caput spermatozoa with condensed but unstabilized chromatin were far more sensitive to acid induced DNA-denaturation than mature cauda stallion spermatozoa (Dias et al., 2006) . Thus, there is a need to further understand how the variability and changes in the degree and type of chromatin stabilization influence the outcome of the AO test to control for potential false negative and false positive results. This need is illustrated by the observations that (i) a high DNA fragmentation index (DFI %) among spermatozoa in raw semen was related to low success after intrauterine insemination (IUI) (Bungum et al., 2007) , but that (ii) the prepared sperm populations that were actually used for the insemination all had low (4 -6%) and normal DFI% (Bungum et al., 2008) . Thus the 'negative impact' of originating from an ejaculate with .30% DFI is associated with the selected sperm population but hidden to the investigator as a 'falsely' normal value for DFI. For the diagnostic value for the individual patient further methodological work is needed to distinguish whether (i) a high DFI means increased vulnerability to acid and other exposures or true DNA damage that can be transmitted to future generations and (ii) a low DFI means a false negative result or no DNA damage.
To adapt the comet assay for spermatozoa, the compact status of the sperm chromatin must again be broken down using procedures that may also induce damage to the DNA. There are no standardized protocols for these procedures, but two methods have emerged: alkaline and neutral conditions. There are few studies relating this assay to clinical fertility status. Therefore, clinically robust cut-off levels remain to be established. As with the TUNEL assay, the accessibility of the DNA can be a limiting factor which needs to be addressed.
Interpretation of any test may be confounded by the presence of dead cells when these tests are performed on unprocessed semen. Dead cells contain fragmented DNA and may bias the overall results. As with all assays examining the quality of semen, a key consideration is the number of cells examined. Counting higher numbers of cells allows greater accuracy (WHO 1999) and as such any assay based on counting a low number of cells will have significantly wide confidence limits. An advantage of flow cytometry, which can be used for TUNEL and SCSA, is that large number of cells can be assessed thereby providing greater accuracy (as long as an account is made for the influence of non-sperm and dead cells).
Other tests revealing DNA accessibility
Chromomycin A3 is a compound that can bind to DNA and fluoresce. Binding to DNA is competitive with protamines and CMA3 fluorescence has therefore been interpreted as evidence for poor protamination (Bianchi et al., 1993) . CMA3 fluorescence is certainly evidence of CMA3 binding to DNA, but this could also be due to increased access to sperm DNA due to assay procedures that may also cause a loosening between DNA and protamines (relative deprotamination). An alternative interpretation would therefore be that sperm with a high degree of CMA3 fluorescence possess DNA that is more easily accessed (and thus, more susceptible to injury), as a result of the relative deprotamination of the chromatin.
The aniline blue test is based on the detection of lysine residues with aniline blue as a measure of an excess of histones remaining bound to the sperm DNA (Dadoune et al., 1988) .
Should DNA tests be based on the whole semen population or the subpopulation prepared for clinical use?
Whether DNA damage tests should be performed before or after sperm preparation depends on the purpose of the investigation. If the aim is to predict the potential for ART success, there is some controversy depending on the tests used. If the SCSA assay is employed, studies suggest that whole semen is more predictive (Larson et al., 2000; Bungum et al., 2007 Bungum et al., , 2008 whereas the TUNEL assay has been shown to be discriminative for clinical pregnancy using either raw semen or cohorts of spermatozoa prepared by density centrifugation for clinical use Borini et al., 2006) .
Whether we measure DNA from sperm taken from whole semen or isolated subpopulations, we cannot expect one single parameter to provide an absolute criterion for fertility or infertility. As for assessment of the diagnostic and prognostic value of traditional semen analysis, our expectations of sperm DNA testing are excessive. A successful ART outcome will also depend on many other traits of sperm quality e.g. capacity to fuse with the oolemma as well as the influences of the oocytes, uterine receptivity and maternal immune system competence.
The usefulness of animal studies
Animal studies are very important to our understanding of the basic biological mechanisms and the consequences of disruption of key processes. These can range from basic fertility studies, where experiments for example in cattle allow multiple inseminations and thus provide valuable preliminary information on potential diagnostic and prognostic assays (Ballachey et al., 1987; Amann and Hammerstedt, 2003) , to developing critical models that offer the ability to perform multi-generational analyses of the consequences of ART. For ART, interpretation of animal studies depends upon an understanding of the differences in animal and human ICSI/IVF. We highlight only a few examples to illustrate how important such studies can be for predicting the future consequences of human ART. As the first example, injecting oocytes with spermatozoa with demonstrated DNA lesions as measured by SCSA has caused multigenerational effects (Fernandez-Gonzalez et al., 2008) . This highlights possible long-term consequences of using sperm with compromised DNA integrity. Two further studies indicate the usefulness of animal models for identifying important areas of research in human ART. In the first, infertile Hook/Hook mice were used to obtain sperm for ICSI (Ward, 2005) . These mice produce severely deformed spermatozoa, yet when these sperm were used for ICSI, apparently normal mice were born. More importantly, the severity of the morphological deformations did not increase in three successive generations. A second study however suggested a potential unexpected problem with ART (Collier et al., 2009) . The clearance of steroids by the placenta was very different in offspring generated by ICSI compared with those generated by normal mating. This points to a potentially important problem that could be monitored in human pregnancies.
Sperm DNA: questions and answers
The relative ease with which animal studies in ART can be performed compared with the same investigations in human patients suggests an obvious need for the expansion of this particular type of research. The dilemma that the field faces is that it is ethically not possible to perform many of the necessary experiments to ensure that ART is completely safe, yet we have an obligation to do some assessment. Animal models can provide a step in this direction.
Clinical uncertainties: the urgency for a robust clinical test
The study of sperm DNA damage is highly relevant in the era of ART, particularly ICSI, because (i) these technologies bypass the barriers of natural selection, (ii) subfertile men possess substantially more sperm DNA damage than do fertile men and (iii) experimentally, sperm DNA damage has been shown to impact negatively on ICSI embryo development, pregnancy rates and offspring health (Ahmadi and Ng, 1999, Fernandez-Gonzalez et al., 2008; Zini et al., 2008) .
There is good evidence to show that infertile men possess substantially more sperm DNA damage than do fertile men although a small percentage of spermatozoa from fertile men also possess detectable levels of DNA damage (Kodama et al., 1997; Evenson et al., 1999 , Spanò et al., 2000 Zini et al., 2001) . The etiology of sperm DNA damage is multi-factorial and may be due to primary testicular or secondary (e.g. environmental) factors. Ultimately, sperm DNA damage is believed to be the result of aberrant protamine expression, excessive ROS generation and abortive apoptosis during spermatogenesis (de Yebra et al., 1993; Carrell and Liu, 2001; Sakkas et al., 2003 ; see also sections: Mechanisms of DNA damage in male germ cells and spermatozoa and The nature of the DNA damage exhibited by human spermatozoa).
Primary testicular factors that may disrupt spermatogenesis and spermiogenesis and subsequently lead to sperm DNA damage include ageing, congenital abnormities (cryptorchidism), genetic defects and idiopathic abnormalities. Extrinsic factors that may cause sperm DNA damage include drugs (e.g. chemotherapy), cigarette smoking, genital tract inflammation, testicular hyperthermia and varicoceles.
Epidemiologic studies of healthy men have demonstrated that the level of sperm DNA damage increases with advancing age (Spano et al., 1998; Wyrobek et al., 2006) . Studies of infertile men have also generally shown that sperm DNA damage increases with advancing age (Moskovtsev et al., 2006; Vagnini et al. 2007; Winkle et al., 2009 ). These findings are in keeping with the age-dependent decline in semen parameters (Sartorius and Nieschlag, 2009) .
Men with cancer (e.g. Hodgkin's lymphoma and testicular cancer) typically have poor semen quality and sperm DNA damage even prior to cancer-specific therapy (O'Flaherty et al., 2008) . They may then experience further testicular damage with the cancer therapy (chemotherapy, radiation; Fossa et al., 1997; Morris, 2002) . The recovery of spermatogenesis may occur months to years after therapy, but evidence of sperm DNA damage may often persist beyond that period (Fossa et al., 1997) . Patients who are scheduled to undergo definitive cancer therapy (surgery, chemotherapy and/or radiation) are strongly encouraged to cryopreserve sperm for future use (Lee et al., 2006) .
Cigarette smoking is associated with lower sperm counts and motility, and an increase in abnormal sperm forms and sperm DNA damage (Spano et al., 1998; Potts et al., 1999) . It is postulated that smoking increases leukocyte-derived ROS production with subsequent adverse effects on mature sperm (Potts et al., 1999) .
Smokers should be counselled to stop smoking.
Post-testicular genital tract infection and inflammation (e.g. epididymo-orchitis, prostatitis) can cause leukocytospermia, and have been associated with increased levels of semen ROS and subsequent sperm DNA damage (Spano et al., 1998; Erenpreiss et al., 2002) . Treatment of these genital tract infections with antibiotics may improve sperm DNA damage (Moskovtsev et al., 2009) .
Testicular hyperthermia has been shown to cause sperm DNA damage and an increase in the histone to protamine ratio in experimental studies (Sailer et al., 1997 , Banks et al., 2005 . Clinically, there is limited evidence to demonstrate a relationship between hyperthermia and sperm DNA damage, however, an association between hyperthermia and reduced male fertility potential has been reported (Thonneau et al., 1998; Evenson et al., 2000) . Certain behaviours (e.g. hot baths, saunas) and occupations (e.g. welders, bakers, prolonged driving) are associated with increased scrotal temperatures (Jung et al., 2002) and these may cause sperm DNA damage. Although men should be counselled to minimize any activity that can increase scrotal temperature, there is only limited evidence to show that this will specifically reduce sperm DNA damage.
Varicoceles have been associated with sperm DNA damage and the damage has been related to levels of oxidative stress in the semen of these infertile men (Saleh et al., 2003) . However, it is unlikely that sperm DNA damage is specific to men with varicocele as men without varicocele (e.g. idiopathic infertility) can also possess high levels of DNA damage (Zini et al., 2001) . Three studies have shown that varicoceletomy may reduce the levels of sperm DNA fragmentation (measured by SCSA or TUNEL assay). However, these studies are all small, uncontrolled, retrospective in design and have only tested one post-operative sperm sample (Zini et al., 2005; Sakamoto et al., 2008; Werthman et al., 2008) . As such, the beneficial effect of varicocelectomy remains to be verified with larger, prospective studies.
It has been proposed that sperm DNA damage may be caused by seminal oxidative stress resulting from antioxidant deficiency, although the evidence in this respect is largely indirect. As such, a number of investigators have evaluated the effects of dietary antioxidant supplementation on sperm DNA integrity. Most of these clinical studies have evaluated men with high levels of sperm DNA damage. In these men, treatment with antioxidant supplements is generally associated with reduced levels of sperm DNA damage and/or improved fertility potential (Kodama et al., 1997; Greco et al., 2005a, b; Menezo et al., 2007; Tremellen et al., 2007; Gil-Villa et al., 2008) . However, these dietary antioxidant studies were small and have not evaluated the mechanism of action of antioxidants: the only end-point that was measured is the integrity of the sperm DNA or pregnancy rate. Moreover, most studies evaluated the effects of a short treatment course (with no long-term follow-up), were not randomized and failed to include a placebo-control group. As such, vitamin supplements (antioxidants) can be offered to men with the understanding that limited clinical outcome data are not yet available to support their use.
Several clinical studies have examined the relationships between sperm DNA damage and reproductive outcomes in the context of natural and ART pregnancies. on the basis of a systematic review and meta-analysis of these studies, sperm DNA damage was found to be associated with lower natural, IUI and IVF pregnancy rates, but not with ICSI pregnancy rates (Collins et al., 2008; Zini and Sigman, 2009 ). Interestingly, the literature strongly suggests that sperm DNA damage is associated with an increased risk of pregnancy loss in those couples undergoing IVF or ICSI (Zini et al., 2008) . Surprisingly there are no data relating sperm DNA damage to late fetal development or post-natal health in humans (Zini et al., 2008) . Nonetheless, the true clinical utility of sperm DNA damage assays remains to be firmly established as the available clinical studies are generally small, heterogeneous and poorly designed, and many do not control for female factors (Collins et al., 2008; Zini and Sigman, 2009) .
While current data suggest that impaired sperm DNA integrity may have the greatest effect (and hence, greatest clinical utility) on IUI pregnancy rates and on pregnancy loss following IVF and ICSI, larger (adequately powered), properly designed and controlled prospective studies are absolutely required to confirm these results. An evaluation of the impact of sperm DNA damage on late fetal and post-natal health is also vital.
Summary and recommendations
Recommendation 1: Fundamental research is urgently required Significant and fundamental questions remain to be answered as part of a detailed understanding of the basic structure of chromatin and its repackaging during spermatogenesis, sperm maturation, ejaculation and during unpackaging in the oocyte. Although we do know how sperm chromatin packaging differs from that of somatic cell chromatin, we do not understand the specifics of how that packaging occurs. We are at the beginning of our understanding and uncertain where in the lifecycle of the cell the DNA damage originates, and uncertain of the causes (e.g. oxidative in nature) or the nature of the damage (e.g. single and/or double strand breaks and/or DNA cross linking). Other basic questions remain unanswered: does the origin and nature of the damage suggest less/more severe consequences? How does the oocyte recognize and repair the damage? Is there a threshold of repair? Is there a degree of damage beyond the oocyte's ability to repair? Additionally, exciting areas are now emerging such as the presence of histones, mature mRNAs and newly described microRNAs in sperm chromatin. Fundamental research is absolutely required to address the key questions.
Recommendation 2: Standardization of clinical assays
There are clear differences in protocols assessing DNA integrity and surprisingly a general lack of awareness of adequate controls both in clinical and epidemiological research. Due to the lack of standardization in methods, it is difficult to determine whether variations in findings are real (related to biology) or due to differences in method. Presently, none of the protocols appear to address the problem of different types of chromatin stabilization. Standardized methods that allow comparison of results from different laboratories are urgently required. For a correct interpretation of data, it is also essential to understand and control for sperm chromatin changes occurring after ejaculation and to distinguish between genuine DNA damage and artifacts due to lack of reagent access to DNA.
Only with standardized protocols and appropriate external quality control (EQA) is it reasonable to implement findings worldwide. For clinically useful cut-off limits, it is also a requirement that the parameter can distinguish between affected and unaffected individuals. To evaluate that, correlations are not adequate-predictive values, likelihood ratios as well as odds' ratios should be calculated to validate the usefulness of a certain parameter. ROC curves can be used to identify possible cut-off levels. Properly controlled studies with sufficiently high numbers of participating patients are more likely to be multicentre studies, which of course require standardized methods and EQA.
An EQA scheme should be developed, similar to that for Basic Semen Analysis run by the ESHRE Special Interest Group in Andrology.
Recommendation 3: Animal models
Models using animal studies should be developed to make predictions for long-term clinical outcomes of ART. Animal models offer the ability to perform multi-generational analyses of the consequences of ART, and to identify potentially hazardous molecular and biological affects of ART. We have highlighted several examples to illustrate how important animal studies can be for predicting the future consequences of human ART. The relative ease with which animal studies in ART can be performed compared with the same investigations in human patients suggests an obvious need for the expansion of this particular type of research.
Recommendation 4: High quality clinical data is urgently required
While current data suggest that impaired sperm DNA integrity may have the greatest effect (and hence, greatest clinical utility) on IUI pregnancy rates and on pregnancy loss following IVF and ICSI, significantly larger (adequately powered), properly designed and controlled prospective studies are absolutely required to confirm these results. Future studies should also aim to assess the relationships between sperm DNA damage and late reproductive outcomes (pregnancy loss, delivery rate and neonatal health) in view of the worrisome postnatal effects observed in animal studies. Sound clinical strategies for sperm DNA testing and subsequent counselling of couples seeking infertility therapies can only be developed after such studies have been undertaken. It is likely that to perform these trials large multicentre studies will be required.
Recommendation 5: Long-term follow-up of art children
It is essential that long-term comprehensive follow-up studies on ART children are performed to ascertain the safety of the procedures we are currently using. To date, there is a paucity of such studies. In general those available have limited power and do not provide comprehensive outcomes. We recommend that follow-up studies of children are performed as a matter of urgency and should include, where Sperm DNA: questions and answers appropriate, cross linking of databases. It is likely that with increasing developments in ART such follow-up studies will need to be continually updated and will involve international consortia.
The requirement for dedicated funding for research in reproductive medicine and infertility
We have identified real progress and presented further fascinating challenges. However, a fundamental impediment to advancement over the past three decades has been the absence of reproductive medicine and infertility research as a strategic priority for national governments and agencies. This has resulted in a paucity of funding. A prerequisite of achieving the above recommendations is for national and international agencies to realize the importance of both basic and clinical research in this area and, to deliver substantial long-term financial support. We anticipate that identifying areas for future research is an essential starting point in meeting this challenge.
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